コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 neutralizing activity present in SARS-CoV-2 immune sera.
2 WT DENV4 to neutralization by DENV3 primary immune sera.
3 dia trachomatis PorB sequence and polyclonal immune sera.
4 be achieved by intravenous injection of the immune sera.
5 d-type DH012 to neutralization by guinea pig immune sera.
6 f parasite Ags unless Ags were injected with immune sera.
7 d with recipients of the Ig-poor fraction of immune sera.
8 ed with granulocytic Ehrlichia (GE)-positive immune sera.
9 mory splenocytes with LCMV-immune B cells or immune sera.
10 ro cultured, host-derived, and tickborne) to immune sera.
11 hich allowed the comparison of preimmune and immune sera.
12 und IgG from ZIKV-immune but not from dengue-immune sera.
13 cell-deficient recipients treated with MCMV immune sera.
14 t impacts antibody recognition by polyclonal immune sera.
15 is resistant to neutralizing human MAbs and immune sera.
16 of DENV1 16007 to neutralization by vaccine immune sera.
17 ciated with ApoE and could be neutralized by immune sera.
18 iral neutralization sensitivity to the early immune sera.
19 completely protected by the transference of immune sera.
20 tion could be enhanced as well as reduced by immune sera.
21 ies would expand the neutralizing breadth of immune sera.
22 ortant for this cross protection mediated by immune sera.
23 absorption of LF-binding antibodies from EF immune sera.
24 doxically increased virion neutralization by immune sera.
25 e new antigens that we confirmed using human immune sera.
26 aive B-cell-deficient mice by inoculation of immune sera.
27 ensitive to neutralization than WT by pooled immune sera.
28 most predominantly recognized antigen by the immune sera.
29 is and bacterial agglutination with anti-CS4 immune sera.
30 t cellular cytotoxicity has been observed by immune sera.
34 pA, two-dimensional immunoblot analysis with immune sera also revealed additional details of the anti
35 bility to resist the bactericidal effects of immune sera and also was observed to increase pathogen s
37 absorption of EF-binding antibodies from LF immune sera and by column absorption of LF-binding antib
38 ened the reactivity of SARS-CoV-2 spike with immune sera and inhibited a subset of neutralizing antib
39 is (ADCP) activities, were present with both immune sera and isolated MAbs, confirming the induction
41 13 also inhibited the GXM binding of GXM-TT immune sera and naturally occurring serum antibodies fro
42 za viruses and facilitate the development of immune sera and neutralizing monoclonal antibodies that
43 tope recognized by all the conjugate vaccine immune sera and strategies for assessing polyclonal Ab a
44 y of primary human and nonhuman primate DENV immune sera and that the hinge region both induces NAbs
47 potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent r
48 els somewhat better than the wild-type gp120 immune sera as a result of an increased elicitation of a
50 us infection survivors demonstrated that the immune sera block the binding of antibodies specific for
51 y, the majority of neutralizing Abs in human immune sera bound to intact virions but not to the ectod
53 clones that reacted specifically with pooled immune sera but not with pooled sera obtained from the s
54 female rats demonstrated that Fusion-F(D12) immune sera, but not purified IgG, neutralized vaccine-t
56 pecific total IgG, IgG1, and IgG2c titers in immune sera by day 77, respectively, and induced balance
57 tigens were identified with C. psittaci B577-immune sera by solid-phase scanning of overlapping octap
58 , the use of experimentally generated animal immune sera can be valuable for measuring antigenic diff
60 odominant and was consistently recognized by immune sera collected at various times during the course
61 y analyses suggested stronger potency of V10 immune sera compared with LcrV in the passive transfer o
63 was significantly delayed in mice receiving immune sera, compared with saline or uninfected serum co
64 Absorption with the immunogen depleted the immune sera completely of anti-Golgi complex Ab (inducib
66 lack B lymphocytes and adoptive transfer of immune sera conferred partial protection to naive mice.
67 We also show that passive transfer of NP-immune sera confers significant TRIM21-dependent protect
68 e observed transmission-blocking activity of immune sera correlated with antibody levels measured by
78 like wild-type gp120 immune sera, GDMR gp120 immune sera failed to neutralize HXBc2, a T-cell line ad
85 the reactivities of anti-rLcrV and anti-rV10 immune sera from cynomolgus macaques, BALB/c mice, and b
88 the chaotropic reagent Urea and probing with immune sera from healthy individuals (n = 109) increased
94 icited a specific IgG response to PI Ag, and immune sera from m1E41920-KLH-immunized mice was able to
95 e targets of naturally acquired immunity and immune sera from messenger RNA lipid nanoparticle immuni
99 s evident in long term infection studies and immune sera from MyD88-deficient mice were able to prote
104 gM was the major detectable antibody (Ab) in immune sera from PIV-vaccinated CD4(+) T cell-deficient
105 cell-deficient mice, and passive transfer of immune sera from PIV-vaccinated CD4(+) T cell-deficient
107 700 proteins was constructed and probed with immune sera from Salmonella-infected mice and humans.
108 neutralization by soluble CD4 (sCD4), pooled immune sera from SIV239-infected rhesus macaques, and mo
109 obing of gonococcal protein microarrays with immune sera from the 2 groups identified multiple vaccin
111 gous Env or challenge strain-specific Env in immune sera from the vaccinated ponies did not correlate
112 ity, and CDC activity of a panel of mAbs and immune sera from these trials on the same two tumor cell
115 cation is increased rather than decreased by immune sera, has been observed in vitro for a large numb
116 ports of enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previ
117 , using monoclonal antibodies (mAbs), animal immune sera, human convalescent sera and human sera from
118 2-type cytokines and SRW-specific Abs in the immune sera in contrast to a direct Th2 response observe
122 vity in vitro, and passive transfer of these immune sera into B. burgdorferi-infected SCID mice cause
124 h LcrV-derived peptides, rV10, but not rLcrV immune sera, lacked antibodies recognizing linear LcrV o
125 specifically to MCA205 tumor cells, and such immune sera mediated tumor cell lysis in the presence of
130 proteins recognized by total IgG and IgG2 in immune sera of outer membrane-vaccinated cattle were det
134 tantly, passive immunization with anti-Ftr1p immune sera protected DKA mice from infection with R. or
136 onstrated that immune cells, with or without immune sera, protected recipients from challenge with pa
141 Antibody competition studies revealed that immune sera raised to high-molecular-weight Delta123 was
149 Nonetheless, systemic administration of immune sera reduced bacterial numbers significantly in n
151 observed, but in vitro analyses of the mouse immune sera revealed that the antiviral activity of the
153 t convalescent sera and mRNA vaccine-induced immune sera showed reduced inhibitory activity against v
155 were used to generate high-titer polyclonal immune sera that demonstrated HPV genotype-restricted re
157 n (NAI) of a broad panel of ferret and mouse immune sera that were raised by infection and recombinan
158 d sera from human adults immunized with AVA (immune sera), the anthrax vaccine currently approved for
159 thermore, passive systemic administration of immune sera to FimH also resulted in reduced bladder col
160 oninhibitory and inhibitory high-titer human immune sera to identify target epitopes associated with
161 ow that the administration of B. burgdorferi-immune sera to IFN-gammaR-deficient mice that have been
164 ell-knockout (KO) mice and by the ability of immune sera to neutralize sporozoite infectivity in mice
165 ly invulnerable to the protective effects of immune sera, unlike spirochetes grown in vitro, which ar
169 ting the site-specific antibodies in vaccine immune sera, we demonstrated that vaccination elicited f
176 hically diverse CSA-binding isolates, rabbit immune sera were screened on four heterologous CSA-bindi
178 in-killed Enterococcus faecalis strains, and immune sera were tested in an opsonophagocytic assay aga
179 ns that selectively and specifically bind to immune sera were then enriched using a multi-step pannin
181 with syngeneic prostate homogenates, and the immune sera were used to screen prostate proteins for im